Understand what it will take for your technology to become part of care.
Assess where your product fits in the disease pathway, what evidence decision-makers need, and which adoption assumptions require testing.
When a successful pilot is not yet a place in the pathway
Moving into a new market, or beyond a pilot site, raises questions the product data alone cannot answer: where the technology changes the pathway, who decides, and what evidence they will expect.
We help you separate what the published evidence shows from what still has to be tested locally with users, evaluators and payers.
Three questions an engagement can answer
- 1
Where could the technology change the diagnostic or treatment pathway?
- 2
Who uses, evaluates, buys and pays for it?
- 3
Which clinical, workflow or reimbursement questions need further investigation?
What you could receive
- Evidence and care-pathway assessment
- Stakeholder and decision-role map
- Evidence-gap and adoption-assumption register
- Priorities for local research and stakeholder validation
Proposed deliverables. Procurement, workflow and reimbursement research depends on the product and markets in scope.
Evidence and expert interpretation, kept distinct
We map the disease pathway and the published evidence relevant to your technology, with each finding linked to its source.
Procurement, workflow and reimbursement findings are not produced automatically by the published evidence base. Where agreed, we investigate them through local stakeholder research.
Our interpretation sets out which adoption assumptions look supported and which need testing, labelled clearly as interpretation.
Frequently asked questions
Can you predict whether our product will be adopted?
No. We identify which adoption assumptions are supported and which need testing. We do not predict adoption conclusively or guarantee approval.
Do you cover every device category?
No. We focus on disease-specific diagnostics and devices where the care pathway and evidence base can be examined in depth. We will tell you early if your product is outside that focus.
Is this a software platform we log into?
No. Systemix is an expert-led service. We deliver source-linked findings, registers and interpretation as agreed deliverables for each engagement, not a self-service tool.
Discuss your adoption question
Tell us the product, the disease area and the markets in scope. We will come back with what a scoped engagement would cover.